Monomer-dependent secondary nucleation in amyloid formation

Area of Science:

• Biochemistry
• Materials Science
• Chemical Engineering

Background:

• Secondary nucleation, where monomers add to existing aggregates, drives autocatalytic self-assembly.
• This process is observed in small molecule crystallization, protein self-assembly into fibrils, and amyloid formation.
• Secondary nucleation contributes to the formation of toxic oligomers in amyloid diseases.

Purpose of the Study:

• To explore the mechanisms and implications of secondary nucleation in self-assembly processes.
• To highlight the role of secondary nucleation in protein aggregation and disease.
• To discuss potential therapeutic strategies targeting secondary nucleation.

Main Methods:

• Kinetic experiments analyzing monomer-only and seeded reactions.
• Isotope labeling techniques to differentiate de novo aggregates from seed fragments.
• Structural specificity and mutation/electrostatic screening analyses.

Main Results:

• Secondary nucleation significantly amplifies self-assembly kinetics.
• Evidence for secondary nucleation can be obtained from seeded kinetic experiments.
• Isotope labeling provides robust confirmation of secondary nucleation.
• Amyloid formation involves toxic oligomers generated via secondary nucleation.
• Secondary nucleation is structurally specific and influenced by mutations and electrostatics.

Conclusions:

• Secondary nucleation is a key amplification mechanism in various self-assembly systems.
• Understanding secondary nucleation is vital for controlling material formation and disease progression.
• Inhibitors of secondary nucleation represent promising therapeutic avenues, particularly for amyloid-related disorders.